|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.810 USD | +2.42% |
|
+5.54% | - |
| 06-29 | Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 398M 348M 321M 295M 559M 38.27B 568M 3.83B 1.5B 18.7B 1.49B 1.46B 64.47B | P/E 2026 * |
-2.36x | P/E 2027 * | -3.06x |
|---|---|---|---|---|---|
| Enterprise Value | 221M 193M 178M 164M 311M 21.29B 316M 2.13B 836M 10.41B 831M 813M 35.87B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.33x |
| Free-Float |
96.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Larimar Therapeutics, Inc.
| 1 day | +2.42% | ||
| 1 week | +5.54% | ||
| Current month | +24.92% | ||
| 1 month | +6.13% | ||
| 3 months | -21.12% | ||
| 6 months | +16.87% |
| 1 week | 3.56 | 4.32 | |
| 1 month | 2.92 | 4.32 | |
| Current year | 2.72 | 6.42 | |
| 1 year | 2.72 | 6.42 | |
| 3 years | 1.61 | 13.68 | |
| 5 years | 1.53 | 15.26 | |
| 10 years | 1.53 | 25.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2020-04-30 | |
Michael Celano
DFI | Director of Finance/CFO | 67 | 2020-05-27 |
Russell Clayton
CTO | Chief Tech/Sci/R&D Officer | 65 | 2023-07-16 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2019-12-31 | |
Joseph Truitt
CHM | Chairman | 61 | 2020-05-27 |
Thomas Hamilton
BRD | Director/Board Member | 58 | 2020-05-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-05 | Buy | Director | 50,000 | 0.0584% | ||
| 05-18 | Free | Director | 55,150 | 0.0644% | ||
| 05-18 | Free | Director | 55,150 | 0.0644% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.42% | +5.54% | +20.57% | +18.69% | 388M | ||
| +3.13% | +13.95% | +64.21% | +94.35% | 55.93B | ||
| -1.39% | -6.15% | +56.05% | +124.73% | 54.49B | ||
| -0.27% | -5.77% | +6.75% | +433.06% | 23.87B | ||
| +1.76% | -1.65% | -16.86% | -15.01% | 22.86B | ||
| +1.62% | +8.47% | +47.79% | -1.59% | 20B | ||
| +1.94% | +0.21% | +39.31% | -27.77% | 17.48B | ||
| +10.00% | -4.30% | +208.33% | +370.99% | 15.39B | ||
| -2.70% | +10.11% | +47.16% | +700.31% | 15.19B | ||
| -0.39% | -1.00% | +26.08% | +186.49% | 14.02B | ||
| Average | +1.63% | +1.27% | +49.94% | +188.42% | 23.96B | |
| Weighted average by Cap. | +1.30% | +0.50% | +51.58% | +169.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 57.06M 49.89M 46.02M 42.31M 80.16M 5.49B 81.53M 549M 216M 2.68B 214M 210M 9.25B |
| Net income | -157M -138M -127M -117M -221M -15.15B -225M -1.52B -595M -7.4B -591M -578M -25.52B | -157M -137M -126M -116M -220M -15.07B -224M -1.51B -592M -7.37B -588M -575M -25.39B |
| Net Debt | -176M -154M -142M -131M -248M -16.97B -252M -1.7B -666M -8.3B -662M -648M -28.59B | -208M -182M -168M -154M -292M -20B -297M -2B -785M -9.78B -781M -764M -33.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | US$3.810 | +2.42% | 1,268,162 |
| 26-07-14 | US$3.720 | -0.13% | 1,842,147 |
| 26-07-13 | US$3.725 | -12.97% | 2,297,804 |
| 26-07-10 | US$4.280 | +3.63% | 3,445,587 |
| 26-07-09 | US$4.130 | +14.40% | 3,823,933 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LRMR Stock
Select your edition
All financial news and data tailored to specific country editions

















